We have a high flyer joining Quetzal (QTZ) to start the week, as it announced the appointment of Tony Quirke as a Non-executive Director with immediate effect.
Traders Cafe with Zak Mir: The Top 20 Stocks For 2022 via Vox Markets
Introduction: At the time of writing the US stock market is set for its 70th record close of the year. Older market watchers will know that a wall of worry is what
Traders Cafe with Zak Mir: The Top 20 Stocks For 2022 via Vox Markets
Introduction: At the time of writing the US stock market is set for its 70th record close of the year. Older market watchers will know that a wall of worry is what
Traders Cafe with Zak Mir: The Top 20 Stocks For 2022 Countdown – 4 to 1 (Part 4) via Vox Markets
The Top 20 For 2022:Â Of course, at this time of the year, everyone and their mother deliver their list for the winners of the New Year, as I have in
Traders Cafe with Zak Mir: The Top 20 Stocks For 2022 Countdown – 9 to 5 (Part 3) via Vox Markets
The Top 20 For 2022:Â Of course, at this time of the year, everyone and their mother deliver their list for the winners of the New Year, as I have in
Traders Cafe with Zak Mir: The Top 20 Stocks For 2022 Countdown – 14 to 10 (Part 2) via Vox Markets
The Top 20 For 2022: Of course, at this time of the year, everyone and their mother deliver their list for the winners of the New Year, as I have
Traders Cafe with Zak Mir: Bulletin Board Heroes, Thursday 30th December 2021 via Vox Markets
Zak Mir looks at some of the most followed small caps in London from a technical perspective. Today’s selection includes Contango, Eurasia, Genedrive, Galileo, Ilika, Napster, Oxford Biodynamics, Pensana, Proton,
Traders Cafe with Zak Mir: The Top 20 Stocks For 2022 Countdown – 20 to 15 (Part 1) via Vox Markets
Introduction: At the time of writing the US stock market is set for its 70th record close of the year. Older market watchers will know that a wall of worry is
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 13th December 2021 via Vox Markets
Zak Mir takes a technical perspective on some of the most followed small caps on the London market. Today’s selection includes Blue, Challenger, Eve, Feedback, Hemo, Live, Midatech, MyHealth, Nanosynth,
RNS Hotlist with Zak Mir: OKYO, C4XD, LIFE, QTZ, DVRG, AXL, KEFI, CORA, ADV, EQT, AMGO, SAE & TUNG via Vox Markets
With a mention in the Sunday Express yesterday helping along, OKYO Pharma (OKYO), a biotechnology company announced that its drug candidate OK-101 which was developed to treat DED through its
Traders Cafe with Zak Mir: THG, ORPH, ORCP, BOOM, DEV, ASLR, HEMO, QTZ, THR, BHL, CRCL, DEFI, HGEN, RENE, DEST & CCZ
It may be that after today’s announcement that bears of THG (THG) feel that they may be on the wrong side of the price action. The company said CEO Matthew